Myomo price target raised to $7.50 from $6.50 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Myomo to $7.50 from $6.50 and keeps a Buy rating on the shares post the Q2 report. The firm says multiple tailwinds are boosting the company to record revenue.